Hepatic glutathione and hepatotoxicity: changes induced by selected narcotics

J Pharmacol Exp Ther. 1982 Jun;221(3):708-14.

Abstract

Propoxyphene and morphine lowered hepatic glutathione and increased serum glutamic-pyruvic transaminase (SGPT) activity when administered to male mice. Maximal changes were seen at 3 to 6 hr after administration, but the effects lasted for as long as 18 hr. Morphine-induced hepatic changes potentiated both acetaminophen and cocaine-induced hepatotoxicity. Naltrexone, a narcotic antagonist, abolished the glutathione depletion produced by both propoxyphene and morphine, but did not alter the propoxyphene-induced elevations of SGPT. Naltrexone also was tested against other narcotic agonists we have previously demonstrated to be hepatotoxic. Naltrexone pretreatment of antagonized L-alpha-acetylmethadol (LAAM)-induced depletion of glutathione and elevations of SGPT. Similarly, naltrexone antagonized norLAAM-induced depletion of glutathione and elevations of SGPT, but only lessened the magnitude of the changes induced by SKF525-A. The narcotic agonists morphine, LAAM, norLAAM and propoxyphene lower hepatic glutathione and induce hepatocellular damage, but these two effects appear to be unrelated.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetaminophen / toxicity
  • Alanine Transaminase / blood
  • Animals
  • Chemical and Drug Induced Liver Injury / metabolism*
  • Cocaine / toxicity
  • Glutathione / metabolism*
  • Liver / metabolism*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Narcotics / pharmacology*
  • Proadifen / pharmacology
  • Time Factors

Substances

  • Narcotics
  • Acetaminophen
  • Proadifen
  • Alanine Transaminase
  • Glutathione
  • Cocaine